Search

everythinglearnresearchcommunity

for

Search:↓

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

PRP shows potential for treating female hair loss, but more research needed.

Latanoprost 0.1% may effectively treat hair loss.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

New test predicts if hair loss treatment will work.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Sulfotransferase in hair follicles helps predict how well minoxidil works for female hair loss.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Finasteride effectively treats hematospermia in 3 months without side effects.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.